India-EU trade deal: SPCs raise fears of delaying tactics
This article was originally published in Scrip
Executive Summary
Indian companies fear that attempts to include provisions that facilitate patent term extensions (through Supplementary Protection Certificates) in the proposed EU-India free trade agreement could see deliberate delaying tactics by firms filing pharmaceutical patents.